Selected research
Industry Growth & Trends
Global Targeted NGS Amplicon Sequencing Services Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Targeted NGS Amplicon Sequencing Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Targeted NGS Amplicon Sequencing Services is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Targeted NGS Amplicon Sequencing Services is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Targeted NGS Amplicon Sequencing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Targeted NGS Amplicon Sequencing Services market include Novogene, BGI (BGI Genomics), Macrogen, Psomagen, SeqMatic, CD Genomics, AllGenetics, Charles River and Source BioScience, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Targeted NGS Amplicon Sequencing Services market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Targeted NGS Amplicon Sequencing Services market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Targeted NGS Amplicon Sequencing Services market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Targeted NGS Amplicon Sequencing Services.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Targeted NGS Amplicon Sequencing Services market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Targeted NGS Amplicon Sequencing Services Market by Company
Novogene
BGI (BGI Genomics)
Macrogen
Psomagen
SeqMatic
CD Genomics
AllGenetics
Charles River
Source BioScience
AGRF
Plasmidsaurus
Eurofins Scientific
Charles River Laboratories
ABM
Zymo Research
Paragon Genomics
Quintara Bio
HyLabs
MUGTC
SeqCoast Genomics
Shanghai Baiqu Biomedical Technology
Illumina
Guangzhou IGE Biotechnology
IDT
Azenta Life Sciences
Eurofins Genomics
Targeted NGS Amplicon Sequencing Services Segment by Type
Single-Gene Sequencing
Multi-Gene Panel Sequencing
Customized Region Sequencing
Targeted NGS Amplicon Sequencing Services Segment by Application
Clinical Molecular Diagnostics
Human Genetics & Population Research
Agricultural Biotechnology & Breeding
Industrial Biotechnology
Others
Targeted NGS Amplicon Sequencing Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Targeted NGS Amplicon Sequencing Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Targeted NGS Amplicon Sequencing Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Targeted NGS Amplicon Sequencing Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Targeted NGS Amplicon Sequencing Services companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Single-Gene Sequencing
- Multi-Gene Panel Sequencing
- Customized Region Sequencing
Applications
- Clinical Molecular Diagnostics
- Human Genetics & Population Research
- Agricultural Biotechnology & Breeding
- Industrial Biotechnology
- Others
Companies covered
- Novogene
- BGI (BGI Genomics)
- Macrogen
- Psomagen
- SeqMatic
- CD Genomics
- AllGenetics
- Charles River
- Source BioScience
- AGRF
- Plasmidsaurus
- Eurofins Scientific
- Charles River Laboratories
- ABM
- Zymo Research
- Paragon Genomics
- Quintara Bio
- HyLabs
- MUGTC
- SeqCoast Genomics
- Shanghai Baiqu Biomedical Technology
- Illumina
- Guangzhou IGE Biotechnology
- IDT
- Azenta Life Sciences
- Eurofins Genomics
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Targeted NGS Amplicon Sequencing Services Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Targeted NGS Amplicon Sequencing Services Market Size by Region (2021-2032)
- 1.4.1 Global Targeted NGS Amplicon Sequencing Services Market Size by Region (2021-2026)
- 1.4.2 Global Targeted NGS Amplicon Sequencing Services Market Size by Region (2027-2032)
- 1.5 Key Regions Targeted NGS Amplicon Sequencing Services Market Size (2021-2032)
- 1.5.1 North America Targeted NGS Amplicon Sequencing Services Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Targeted NGS Amplicon Sequencing Services Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Targeted NGS Amplicon Sequencing Services Market Size Growth Rate (2021-2032)
- 1.5.4 South America Targeted NGS Amplicon Sequencing Services Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Targeted NGS Amplicon Sequencing Services Market Size Growth Rate (2021-2032)
2 Targeted NGS Amplicon Sequencing Services Market by Type
- 2.1 Type Introduction
- 2.1.1 Single-Gene Sequencing
- 2.1.2 Multi-Gene Panel Sequencing
- 2.1.3 Customized Region Sequencing
- 2.2 Global Targeted NGS Amplicon Sequencing Services Market Size by Type
- 2.2.1 Global Targeted NGS Amplicon Sequencing Services Market Size Overview by Type (2021-2032)
- 2.2.2 Global Targeted NGS Amplicon Sequencing Services Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Targeted NGS Amplicon Sequencing Services Market Size Forecasted by Type (2027-2032)
- 2.3 Global Targeted NGS Amplicon Sequencing Services Market Size by Regions
- 2.3.1 North America Targeted NGS Amplicon Sequencing Services Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Targeted NGS Amplicon Sequencing Services Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Targeted NGS Amplicon Sequencing Services Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Targeted NGS Amplicon Sequencing Services Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Targeted NGS Amplicon Sequencing Services Market Size Breakdown by Type (2021-2026)
3 Targeted NGS Amplicon Sequencing Services Market by Application
- 3.1 Type Introduction
- 3.1.1 Clinical Molecular Diagnostics
- 3.1.2 Human Genetics & Population Research
- 3.1.3 Agricultural Biotechnology & Breeding
- 3.1.4 Industrial Biotechnology
- 3.1.5 Others
- 3.2 Global Targeted NGS Amplicon Sequencing Services Market Size by Application
- 3.2.1 Global Targeted NGS Amplicon Sequencing Services Market Size Overview by Application (2021-2032)
- 3.2.2 Global Targeted NGS Amplicon Sequencing Services Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Targeted NGS Amplicon Sequencing Services Market Size Forecasted by Application (2027-2032)
- 3.3 Global Targeted NGS Amplicon Sequencing Services Market Size by Regions
- 3.3.1 North America Targeted NGS Amplicon Sequencing Services Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Targeted NGS Amplicon Sequencing Services Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Targeted NGS Amplicon Sequencing Services Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Targeted NGS Amplicon Sequencing Services Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Targeted NGS Amplicon Sequencing Services Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Targeted NGS Amplicon Sequencing Services Industry Trends
- 4.2 Targeted NGS Amplicon Sequencing Services Industry Drivers
- 4.3 Targeted NGS Amplicon Sequencing Services Industry Opportunities and Challenges
- 4.4 Targeted NGS Amplicon Sequencing Services Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Targeted NGS Amplicon Sequencing Services Revenue (2021-2026)
- 5.2 Global Targeted NGS Amplicon Sequencing Services Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Targeted NGS Amplicon Sequencing Services Key Company Headquarters & Area Served
- 5.4 Global Targeted NGS Amplicon Sequencing Services Company, Product Type & Application
- 5.5 Global Targeted NGS Amplicon Sequencing Services Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Targeted NGS Amplicon Sequencing Services Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Targeted NGS Amplicon Sequencing Services Players Market Share by Revenue in 2025
- 5.6.3 2025 Targeted NGS Amplicon Sequencing Services Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Novogene
- 6.1.1 Novogene Company Information
- 6.1.2 Novogene Business Overview
- 6.1.3 Novogene Targeted NGS Amplicon Sequencing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Novogene Targeted NGS Amplicon Sequencing Services Product Portfolio
- 6.1.5 Novogene Recent Developments
- 6.2 BGI (BGI Genomics)
- 6.2.1 BGI (BGI Genomics) Company Information
- 6.2.2 BGI (BGI Genomics) Business Overview
- 6.2.3 BGI (BGI Genomics) Targeted NGS Amplicon Sequencing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 BGI (BGI Genomics) Targeted NGS Amplicon Sequencing Services Product Portfolio
- 6.2.5 BGI (BGI Genomics) Recent Developments
- 6.3 Macrogen
- 6.3.1 Macrogen Company Information
- 6.3.2 Macrogen Business Overview
- 6.3.3 Macrogen Targeted NGS Amplicon Sequencing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Macrogen Targeted NGS Amplicon Sequencing Services Product Portfolio
- 6.3.5 Macrogen Recent Developments
- 6.4 Psomagen
- 6.4.1 Psomagen Company Information
- 6.4.2 Psomagen Business Overview
- 6.4.3 Psomagen Targeted NGS Amplicon Sequencing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Psomagen Targeted NGS Amplicon Sequencing Services Product Portfolio
- 6.4.5 Psomagen Recent Developments
- 6.5 SeqMatic
- 6.5.1 SeqMatic Company Information
- 6.5.2 SeqMatic Business Overview
- 6.5.3 SeqMatic Targeted NGS Amplicon Sequencing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 SeqMatic Targeted NGS Amplicon Sequencing Services Product Portfolio
- 6.5.5 SeqMatic Recent Developments
- 6.6 CD Genomics
- 6.6.1 CD Genomics Company Information
- 6.6.2 CD Genomics Business Overview
- 6.6.3 CD Genomics Targeted NGS Amplicon Sequencing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 CD Genomics Targeted NGS Amplicon Sequencing Services Product Portfolio
- 6.6.5 CD Genomics Recent Developments
- 6.7 AllGenetics
- 6.7.1 AllGenetics Company Information
- 6.7.2 AllGenetics Business Overview
- 6.7.3 AllGenetics Targeted NGS Amplicon Sequencing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 AllGenetics Targeted NGS Amplicon Sequencing Services Product Portfolio
- 6.7.5 AllGenetics Recent Developments
- 6.8 Charles River
- 6.8.1 Charles River Company Information
- 6.8.2 Charles River Business Overview
- 6.8.3 Charles River Targeted NGS Amplicon Sequencing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Charles River Targeted NGS Amplicon Sequencing Services Product Portfolio
- 6.8.5 Charles River Recent Developments
- 6.9 Source BioScience
- 6.9.1 Source BioScience Company Information
- 6.9.2 Source BioScience Business Overview
- 6.9.3 Source BioScience Targeted NGS Amplicon Sequencing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Source BioScience Targeted NGS Amplicon Sequencing Services Product Portfolio
- 6.9.5 Source BioScience Recent Developments
- 6.10 AGRF
- 6.10.1 AGRF Company Information
- 6.10.2 AGRF Business Overview
- 6.10.3 AGRF Targeted NGS Amplicon Sequencing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 AGRF Targeted NGS Amplicon Sequencing Services Product Portfolio
- 6.10.5 AGRF Recent Developments
- 6.11 Plasmidsaurus
- 6.11.1 Plasmidsaurus Company Information
- 6.11.2 Plasmidsaurus Business Overview
- 6.11.3 Plasmidsaurus Targeted NGS Amplicon Sequencing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Plasmidsaurus Targeted NGS Amplicon Sequencing Services Product Portfolio
- 6.11.5 Plasmidsaurus Recent Developments
- 6.12 Eurofins Scientific
- 6.12.1 Eurofins Scientific Company Information
- 6.12.2 Eurofins Scientific Business Overview
- 6.12.3 Eurofins Scientific Targeted NGS Amplicon Sequencing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Eurofins Scientific Targeted NGS Amplicon Sequencing Services Product Portfolio
- 6.12.5 Eurofins Scientific Recent Developments
- 6.13 Charles River Laboratories
- 6.13.1 Charles River Laboratories Company Information
- 6.13.2 Charles River Laboratories Business Overview
- 6.13.3 Charles River Laboratories Targeted NGS Amplicon Sequencing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Charles River Laboratories Targeted NGS Amplicon Sequencing Services Product Portfolio
- 6.13.5 Charles River Laboratories Recent Developments
- 6.14 ABM
- 6.14.1 ABM Company Information
- 6.14.2 ABM Business Overview
- 6.14.3 ABM Targeted NGS Amplicon Sequencing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 ABM Targeted NGS Amplicon Sequencing Services Product Portfolio
- 6.14.5 ABM Recent Developments
- 6.15 Zymo Research
- 6.15.1 Zymo Research Company Information
- 6.15.2 Zymo Research Business Overview
- 6.15.3 Zymo Research Targeted NGS Amplicon Sequencing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Zymo Research Targeted NGS Amplicon Sequencing Services Product Portfolio
- 6.15.5 Zymo Research Recent Developments
- 6.16 Paragon Genomics
- 6.16.1 Paragon Genomics Company Information
- 6.16.2 Paragon Genomics Business Overview
- 6.16.3 Paragon Genomics Targeted NGS Amplicon Sequencing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Paragon Genomics Targeted NGS Amplicon Sequencing Services Product Portfolio
- 6.16.5 Paragon Genomics Recent Developments
- 6.17 Quintara Bio
- 6.17.1 Quintara Bio Company Information
- 6.17.2 Quintara Bio Business Overview
- 6.17.3 Quintara Bio Targeted NGS Amplicon Sequencing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 Quintara Bio Targeted NGS Amplicon Sequencing Services Product Portfolio
- 6.17.5 Quintara Bio Recent Developments
- 6.18 HyLabs
- 6.18.1 HyLabs Company Information
- 6.18.2 HyLabs Business Overview
- 6.18.3 HyLabs Targeted NGS Amplicon Sequencing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 HyLabs Targeted NGS Amplicon Sequencing Services Product Portfolio
- 6.18.5 HyLabs Recent Developments
- 6.19 MUGTC
- 6.19.1 MUGTC Company Information
- 6.19.2 MUGTC Business Overview
- 6.19.3 MUGTC Targeted NGS Amplicon Sequencing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.19.4 MUGTC Targeted NGS Amplicon Sequencing Services Product Portfolio
- 6.19.5 MUGTC Recent Developments
- 6.20 SeqCoast Genomics
- 6.20.1 SeqCoast Genomics Company Information
- 6.20.2 SeqCoast Genomics Business Overview
- 6.20.3 SeqCoast Genomics Targeted NGS Amplicon Sequencing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.20.4 SeqCoast Genomics Targeted NGS Amplicon Sequencing Services Product Portfolio
- 6.20.5 SeqCoast Genomics Recent Developments
- 6.21 Shanghai Baiqu Biomedical Technology
- 6.21.1 Shanghai Baiqu Biomedical Technology Company Information
- 6.21.2 Shanghai Baiqu Biomedical Technology Business Overview
- 6.21.3 Shanghai Baiqu Biomedical Technology Targeted NGS Amplicon Sequencing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.21.4 Shanghai Baiqu Biomedical Technology Targeted NGS Amplicon Sequencing Services Product Portfolio
- 6.21.5 Shanghai Baiqu Biomedical Technology Recent Developments
- 6.22 Illumina
- 6.22.1 Illumina Company Information
- 6.22.2 Illumina Business Overview
- 6.22.3 Illumina Targeted NGS Amplicon Sequencing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.22.4 Illumina Targeted NGS Amplicon Sequencing Services Product Portfolio
- 6.22.5 Illumina Recent Developments
- 6.23 Guangzhou IGE Biotechnology
- 6.23.1 Guangzhou IGE Biotechnology Company Information
- 6.23.2 Guangzhou IGE Biotechnology Business Overview
- 6.23.3 Guangzhou IGE Biotechnology Targeted NGS Amplicon Sequencing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.23.4 Guangzhou IGE Biotechnology Targeted NGS Amplicon Sequencing Services Product Portfolio
- 6.23.5 Guangzhou IGE Biotechnology Recent Developments
- 6.24 IDT
- 6.24.1 IDT Company Information
- 6.24.2 IDT Business Overview
- 6.24.3 IDT Targeted NGS Amplicon Sequencing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.24.4 IDT Targeted NGS Amplicon Sequencing Services Product Portfolio
- 6.24.5 IDT Recent Developments
- 6.25 Azenta Life Sciences
- 6.25.1 Azenta Life Sciences Company Information
- 6.25.2 Azenta Life Sciences Business Overview
- 6.25.3 Azenta Life Sciences Targeted NGS Amplicon Sequencing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.25.4 Azenta Life Sciences Targeted NGS Amplicon Sequencing Services Product Portfolio
- 6.25.5 Azenta Life Sciences Recent Developments
- 6.26 Eurofins Genomics
- 6.26.1 Eurofins Genomics Company Information
- 6.26.2 Eurofins Genomics Business Overview
- 6.26.3 Eurofins Genomics Targeted NGS Amplicon Sequencing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.26.4 Eurofins Genomics Targeted NGS Amplicon Sequencing Services Product Portfolio
- 6.26.5 Eurofins Genomics Recent Developments
7 North America
- 7.1 North America Targeted NGS Amplicon Sequencing Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Targeted NGS Amplicon Sequencing Services Market Size by Country (2021-2026)
- 7.3 North America Targeted NGS Amplicon Sequencing Services Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Targeted NGS Amplicon Sequencing Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Targeted NGS Amplicon Sequencing Services Market Size by Country (2021-2026)
- 8.3 Europe Targeted NGS Amplicon Sequencing Services Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Targeted NGS Amplicon Sequencing Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Targeted NGS Amplicon Sequencing Services Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Targeted NGS Amplicon Sequencing Services Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Targeted NGS Amplicon Sequencing Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Targeted NGS Amplicon Sequencing Services Market Size by Country (2021-2026)
- 10.3 South America Targeted NGS Amplicon Sequencing Services Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Targeted NGS Amplicon Sequencing Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Targeted NGS Amplicon Sequencing Services Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Targeted NGS Amplicon Sequencing Services Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst